Press Releases

February 24, 2015 -- Glucose Health, Inc. Announces FDA Facility Registration

WEST PALM BEACH, FL – Glucose Health, Inc. (OTC: GLUC) today announced its has completed Food & Drug Administration (FDA) facility registration, a compliance procedure for manufacturers of dietary and nutritional supplements. FDA facility registration is the final step in a series regulatory compliance procedures implemented by the Company, beginning in fourth quarter of 2014.

Glucose Health, Inc. CEO Murray Fleming commented:

“Compliance with FDA regulations is an essential prerequisite to Glucose Health, Inc. products being vetted and approved for sale on the shelves...

Read more

January 27, 2015 -- Glucose Health, Inc. Announces Initial Filing with US Patent & Trademark Office

WEST PALM BEACH, FL – Glucose Health, Inc. (OTC: GLUC) today announced the filing of its initial application for trademark protection related to its Glucose Health line of dietary products, with the United States Trademark and Patent Office (USPTO).  

If the Company’s application is successful and a trademark is awarded by the USPTO, a legal presumption of the Company’s ownership nationwide of Glucose Health, and the exclusive right to use a trademark on or in connection with all Glucose Health branded products, as set forth in...

Read more


Locally made Glucose Health seeks a place with retailers

Submitted by The City Wire Staff on Thu, 01/08/2015 - 6:27pm

The nutritional supplement startup Glucose Health has big plans to launch a powdered tea mix that helps Type 2 diabetics maintain blood sugar balance. The drink mix is being compounded by John Lykins, a local pharmacist and the owner of Natural Solutions Labs...

Read more

January 7, 2015 -- Glucose Health, Inc. Completes Implementation of FDA Good Manufacturing Practices

WEST PALM BEACH, FL – Glucose Health, Inc. (OTC: GLUC) today announced it has completed implementation of Food and Drug Administration (FDA) Current Good Manufacturing Practices (CGMP).  The Dietary Supplement (DS) CGMP rule in 21 CFR part 111 of the FDA's regulations requires companies which manufacture, package, label, or hold a dietary supplement to establish and follow current good manufacturing practice to ensure the quality of the dietary supplement and to ensure that the dietary supplement is packaged and labeled as specified in the master manufacturing record.


Read more